Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
Abstract Most conventional insomnia medications are gamma‐aminobutylic acid receptor agonists. However, physical dependence is a concern and one of the major limiting factors for long‐term treatment. The dual orexin receptor antagonists, suvorexant and lemborexant, were recently approved for treatin...
Saved in:
Main Authors: | Taro Kishi (Author), Maika Nishida (Author), Michinori Koebis (Author), Takehiro Taninaga (Author), Kenzo Muramoto (Author), Naoki Kubota (Author), Margaret Moline (Author), Kenji Sakuma (Author), Makoto Okuya (Author), Ikuo Nomura (Author), Nakao Iwata (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
by: Taro Kishi, et al.
Published: (2019) -
Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta‐analysis of phase 3 trials in Japan
by: Taro Kishi, et al.
Published: (2020) -
Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan
by: Taro Kishi, et al.
Published: (2020) -
Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review
by: Taro Kishi, et al.
Published: (2021) -
Body composition in Japanese patients with psychiatric disorders: A cross‐sectional study
by: Taro Kishi, et al.
Published: (2021)